Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
10/2004
10/14/2004US20040204257 System for and a method of manufacturing personal golf putters
10/14/2004DE10315572A1 Substituierte Pyrazole Substituted pyrazoles
10/14/2004DE10315570A1 New 1-aryl-1,2,3-triazole derivatives useful for treating e.g. schizophrenia, depression, dementia, Parkinson's disease or Alzheimer's disease, are glycine transporter inhibitors
10/14/2004DE10315569A1 Substituierte Pyrazolverbindungen Substituted pyrazole
10/14/2004DE10315377A1 New carbonyl-substituted carbocyclic or heterocyclic compounds, are factor Xa and factor VIIa inhibitors useful e.g. for treating thrombosis, myocardial infarction, arteriosclerosis, inflammation or tumors
10/14/2004CA2521073A1 Chemical compounds for the treatment of chemokine mediated disease state
10/14/2004CA2520896A1 Indole acetamides as inhibitors of the hepatitis c virus ns5b polymerase
10/14/2004CA2520894A1 Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses
10/14/2004CA2520863A1 4-ring imidazole derivatives as modulators of metabotropic glutamate receptor-5
10/14/2004CA2520764A1 4-substituted quinolein derivatives with antimicrobial activity
10/14/2004CA2520724A1 Benzopyran compounds useful for treating inflammatory conditions
10/14/2004CA2520682A1 Crystalline n-formyl hydroxylamine compounds
10/14/2004CA2520674A1 Process for making substituted pyrazoles
10/14/2004CA2520493A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
10/14/2004CA2520465A1 Bi-cyclic pyrimidine inhibitors of tgf.beta.
10/14/2004CA2519954A1 Benzamide modulators of metabotropic glutamate receptors
10/14/2004CA2519899A1 Ophthalmic compositions for treating ocular hypertension
10/14/2004CA2518913A1 Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof
10/14/2004CA2518465A1 Dipeptidyl peptidase inhibitors
10/13/2004EP1466906A1 Heterocyclic urea and related compounds useful as anti-inflammatory agents
10/13/2004EP1466904A1 Biaryl compound and use thereof
10/13/2004EP1466902A1 Androgen receptor antagonists
10/13/2004EP1466901A1 Serotonine reuptake inhibitor
10/13/2004EP1466898A1 Beta-amyloid protein production/secretion inhibitors
10/13/2004EP1466897A1 Process for the preparation of organic compounds containing a sulfinyl or sulfonyl group in the presence of epsilon-phthalimidoperhexanoic acid
10/13/2004EP1466605A2 Calcium channel blockers
10/13/2004EP1466603A2 Novel catechols as antimicrobial agents
10/13/2004EP1465892A1 Glycinamides as factor xa inhibitors
10/13/2004EP1465891A2 Inhibitors of dipeptidyl peptidase iv
10/13/2004EP1465890A1 Stable lansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol
10/13/2004EP1465889A1 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
10/13/2004EP1465888A2 Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues
10/13/2004EP1465886A1 Bipyridinyl derivatives as a highly selective cyclooxygenase-2 inhibitor
10/13/2004EP1465880A1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
10/13/2004EP1465875A1 Novel alkansulfonamides as endothelin antagonists
10/13/2004EP1465872A1 4-sulfide/sulfoxide/sulfonyl-1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor
10/13/2004EP1465871A1 Pyrazole derivatives for use in diseases associated with the 5-ht2c receptor
10/13/2004EP1465869A1 Modulators of lxr
10/13/2004EP1465867A1 Ligands of melanocortin receptors and compositions and methods related thereto
10/13/2004EP1465864A1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
10/13/2004EP1465863A1 Potassium channel modulators
10/13/2004EP1465861A1 Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors
10/13/2004EP1465716A1 Purification of impure materials using non-aqueous solvents
10/13/2004EP1465635A2 Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1h-benzoimidazole analogues
10/13/2004EP1465633A1 Quinazolinone compounds in combined modalities for improved cancer treatment
10/13/2004EP1465632A1 Quinazoline derivatives for the treatment of abnormal cell growth
10/13/2004EP1465631A2 Pyrimidine a2b selective antagonist compounds, their synthesis and use
10/13/2004EP1465630A1 Cyclic urea derivatives with 5-ht2c receptor activity
10/13/2004EP1465626A2 Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses
10/13/2004EP1397137A4 Hydantion derivatives as inhibitors of matrix metalloproteinases
10/13/2004EP1322309A4 High affinity small molecule c5a receptor modulators
10/13/2004EP1280797B1 Inhibitors of dipeptidyl peptidase iv
10/13/2004EP1165533B1 Compounds and methods for treatment of asthma, allergy and inflammatory disorders
10/13/2004EP1150954B1 Anti-imflammatory indole derivatives
10/13/2004EP1102763B1 Fsh mimetics for the treatment of infertility
10/13/2004EP1097142B1 Phthalazine derivatives phosphodiesterase 4 inhibitors
10/13/2004EP1086086B1 Imidazolyl derivatives and their use as somatostatin receptor ligands
10/13/2004EP0802912B1 Piperidine derivatives having tachykinin antagonist activity
10/13/2004EP0736036B1 Kininogen inhibitors
10/13/2004CN1537112A Pyrimidine compound
10/13/2004CN1537110A Process for producing pylidine compound
10/13/2004CN1537105A Quinazolines as MMP-13 inhibitors
10/13/2004CN1537104A Pyrimidine derivatives useful as selective COX-2 inhibitors
10/13/2004CN1537102A Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors
10/13/2004CN1537101A Pyridine matrix metalloproteinase inhibitors
10/13/2004CN1537100A Substituted 2-pyrrole cyclohexan-1,4-diamine derivatives
10/13/2004CN1537001A Malonyl-COA decarboxylase inhibitors useful as metabolic modulators
10/13/2004CN1535968A Tetrahydro pyridyl or pyridyl heterocycle derivative
10/13/2004CN1535966A Indazole derivative for pestide
10/13/2004CN1535958A Alpha-substituted pyrimidine. thioalkyl and alkyl ether compound
10/13/2004CN1535682A Medicine for improved bladder excretion capacity
10/13/2004CN1170822C Imidazole compounds and medicinal use thereof
10/13/2004CN1170819C Piperidine alcohols
10/13/2004CN1170538C Farnesyl protein transferase inhibitors for treating arthropathies
10/12/2004USRE38624 Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and process for their preparation
10/12/2004US6803470 2-amino-6-(2,4,5-substituted-phenyl)-pyridines
10/12/2004US6803468 Process for the synthesis of n-(5-methylnicontinoyl)-4 hydroxypiperidine, a key intermediate of rupatadine
10/12/2004US6803384 Diaminopropionic acid derivatives
10/12/2004US6803380 5-aryl-1h-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions containing them
10/12/2004US6803374 Compounds useful for treating hepatitis C virus
10/12/2004US6803370 Compounds for use in the treatment of asthma, alzheimer's, diabetes, atherosclerosis, inflammatory bowel disease, arthritis, tumor metastasis, ischemia and brain disorders
10/12/2004US6803369 Compounds and methods for the treatment of neoplastic disease
10/12/2004US6803364 Il-5 inhibiting 6-azauracil derivatives
10/12/2004US6803362 Heterocyclic compounds
10/07/2004WO2004086050A2 Labelling agents for mass spectrometry comprising tertiary amines
10/07/2004WO2004085431A1 Prostaglandin analogs as ep4 receptor antagonists
10/07/2004WO2004085430A1 Prostaglandin analogs as ep4 receptor agonists
10/07/2004WO2004085425A1 Fused azoles such as 2,5-disubstituted benzimidazoles, benzoxazoles and benzothiazoles as kinase inhibitors
10/07/2004WO2004085424A1 Process for production of sulfoxide derivatives or salts thereof in the amorphous state
10/07/2004WO2004085423A1 Piperidine derivatives for the treatment of chemokine or h1 mediated disease state
10/07/2004WO2004085422A1 Water-soluble thalidomine derivatives
10/07/2004WO2004085418A2 Xanthones, thioxanthones and acridinones as dna-pk inhibitors
10/07/2004WO2004085409A2 Compounds and libraries of pyridines, pyrazines, imidazo[1,2-a]pyrazines and 1h-imidazo[4,5-b]pyrazin-2-ones and first and second medical uses thereof
10/07/2004WO2004085408A1 2, 3, 6-trisubstituted-4-pyrimidone derivatives
10/07/2004WO2004085406A1 Benzyl-pyridazinons as reverse transcriptase inhibitors
10/07/2004WO2004085404A1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use of the same as medicaments, and medicament containing such compounds
10/07/2004WO2004085401A1 1,2,4-substituted 1,2,3,4-tetrahydro-and 1,2 dihydro-quinoline and 1,2,3,4-tetrahydro-quinoxaline derivatives as cetp inhibitors for the treatment of atherosclerosis and obesity
10/07/2004WO2004085385A2 Cannabinoid receptor ligands
10/07/2004WO2004085382A1 Compound inhibiting in vivo phosphorus transport and medicine containing the same
10/07/2004WO2004084901A1 Methods for treating or preventing an inflammatory or metabolic condition by inhibiting jnk
1 ... 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 ... 1080